Long-term paclitaxel-eluting stent outcomes in elderly patients.


BACKGROUND Although drug-eluting stents have become a mainstay of percutaneous coronary intervention, information about drug-eluting stents outcomes in elderly patients is limited. Data from the paclitaxel-eluting stent (PES) trials and registries were pooled to assess PES benefits relative to advancing patient age, including comparison with bare-metal… (More)
DOI: 10.1161/CIRCINTERVENTIONS.109.855221


11 Figures and Tables